JNC 7 vs ASCVD risk — what came first

And quick trivia from a hypertension follow-up this morning: JNC 7 dropped in 2003, the pooled cohort ASCVD risk calculator arrived in 2013 — curious which one shifted your patient-centered conversations most in chronic disease visits, and why? I’ve found the risk calculator can open doors for shared decision-making, but I still lean on JNC basics when we’re titrating meds…

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌⁠‌‌‌⁠​‍‌⁠​⁠‌‍‌‌‌⁠​​‌⁠​‍‌‍​‌‌‍​⁠‌⁠‌​‌‍‍‌‌⁠‌​‌‍‍‌‌‍⁠⁠‌‍⁠‍‌‍‌‌‌⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‌​⁠‍​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠​⁠​⁠​​​⁠​‍‌​‍‍‌‍‍⁠​⁠‌⁠‌‍‍‌​⁠‌‍‌‍​‍‌​‌‌‌​⁠⁠‌‍‌⁠‌‌‍‌‌⁠‍‌‌⁠‍‌‌​‌⁠​‍​‍‌⁠⁠‌

I’m with you — the 2013 pooled cohort calculator shifted my conversations way more than JNC 7 in 2003. I’ll pull up ASCVD Risk Estimator + in the room and use the “what if” to show how a statin or a 10 mmHg SBP drop changes 10‑yr risk, then tie med titration to that and their home BP log. Caveat: , in older patients it inflates risk and the race input is clunky, so I lean on lifetime risk or add CAC talk when it’s borderline.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌⁠‌‌‌⁠​‍‌⁠​⁠‌‍‌‌‌⁠​​‌⁠​‍‌‍​‌‌‍​⁠‌⁠‌​‌‍‍‌‌⁠‌​‌‍‍‌‌‍⁠⁠‌‍⁠‍‌‍‌‌‌⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​​​⁠​‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​⁠‍​⁠‌⁠‌‌​​‌⁠‍‌​⁠‌‍‌‍‍‌‌​‌‍‌‌​⁠‌‌‌‌‌​‌‍‌​‍‌‌‍‌​‌‍‌‍‌​⁠‍‌⁠‌​‌​⁠⁠​‍​‍‌⁠⁠‌